NASDAQ : ILMN
Illumina, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 235.99 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 35.68B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 35.68B |
| Enterprise Value | 36.66B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 151.20M |
| Shares Outstanding | 151.20M |
| Shares Change (YoY) | -2.38% |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 108.58% |
| Float | 150.50M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 40.51 |
| Forward PE | 39.76 |
| PS Ratio | 7.86 |
| Forward PS | 7.40 |
| PB Ratio | 11.41 |
| P/TBV Ratio | 24.27 |
| P/FCF Ratio | 33.76 |
| P/OCF Ratio | 29.01 |
| PEG Ratio | 3.68 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 40.96 |
| EV / Sales | 8.08 |
| EV / EBITDA | 32.10 |
| EV / EBIT | 42.38 |
| EV / FCF | 34.68 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.63 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 1.90 |
| Debt / FCF | 2.19 |
| Interest Coverage | 8.92 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 32.39% |
| Return on Assets (ROA) | 8.32% |
| Return on Invested Capital (ROIC) | 17.59% |
| Return on Capital Employed (ROCE) | 15.29% |
| Weighted Average Cost of Capital (WACC) | 11.52% |
| Revenue Per Employee | $450,298 |
| Profits Per Employee | $88,790 |
| Employee Count | 10,080 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.33 |
Taxes
| Measure | Value |
|---|
| Income Tax | 163.00M |
| Effective Tax Rate | 15.41% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.42 |
| 52-Week Price Change | +148.33% |
| 50-Day Moving Average | 249.30 |
| 200-Day Moving Average | 176.10 |
| Relative Strength Index (RSI) | 38.58 |
| Average Volume (20 Days) | 2,489,022 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.89M |
| Short Previous Month | 9.47M |
| Short % of Shares Out | 5.22% |
| Short % of Float | 5.24% |
| Short Ratio (days to cover) | 1.86 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.54B |
| Gross Profit | 3.07B |
| Operating Income | 865.00M |
| Pretax Income | 1.06B |
| Net Income | 895.00M |
| EBITDA | 1.14B |
| EBIT | 865.00M |
| Earnings Per Share (EPS) | $5.83 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.34B |
| Total Debt | 2.31B |
| Net Cash | -976.00M |
| Net Cash Per Share | -$6.46 |
| Equity (Book Value) | 3.15B |
| Book Value Per Share | 20.69 |
| Working Capital | 1.88B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.23B |
| Capital Expenditures | -173.00M |
| Depreciation & Amortization | 277.00M |
| Net Borrowing | -208.00M |
| Free Cash Flow | 1.06B |
| FCF Per Share | $6.99 |
Margins
| Measure | Value |
|---|
| Gross Margin | 67.68% |
| Operating Margin | 19.06% |
| Pretax Margin | 23.31% |
| Profit Margin | 19.72% |
| EBITDA Margin | 25.16% |
| EBIT Margin | 19.06% |
| FCF Margin | 23.29% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.38% |
| Shareholder Yield | 2.38% |
| Earnings Yield | 2.47% |
| FCF Yield | 2.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $261.60 |
| Price Target Difference | 10.85% |
| Analyst Consensus | Hold |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | 7.01% |
| EPS Growth Forecast (3Y) | 13.58% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 23, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.17 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |